Group News
-
-
- 11.19 2023
Tianjin Pharmaceutical Steadily Improved Its Ranking in the Top 100 Pharmaceutical Industries in China
On November 17th, 2023, the "China Pharmaceutical Industry Development Conference 2023" jointly organized by the Ministry of Industry and Information Technology, the People's Government of Beijing Municipality, National Health Commission, State-owned Assets Supervision and Administration Commission of the State Council, National Administration of Traditional Chinese Medicine and National Medical Products Administration opened in Beijing.
-
-
-
- 12.08 2023
Tianjin Pharmaceutical Holdings Co., Ltd. won the title of "Model Tianjin-the most socially responsible enterprise" again
On December 7th, the award ceremony for the 13th "Model Tianjin-the Most Socially Responsible Enterprise" Selection Event 2023 was successfully held in Tianjin Media Grand Theatre, and Tianjin Pharmaceutical Holdings Co., Ltd. was once awarded "the most socially responsible enterprise" again.
-
-
-
- 11.06 2023
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited passed HAAL certification, speeding up the expansion to international HALAL market.
Recently, six products in the international market, namely Suxiao Jiuxin Pills produced by the No.6 Chinese Medincine Plant of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, Wuji Baifeng Pills and Liuwei Dihuang Pills produced by Da Ren Tang, Refined Yinqiao Jiedu Tablets, Xinmingmu Shangqing Tablets and Xinqingfei Yihuo Tablets produced by Long Shun Rong and Zhongxin Pharmaceutical Factory, have obtained the HALAL CERTIFICATE, marking that the quality and safety standards, production environment and management system of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited products have got halal recognition.
-
